Oncology & Cancer

Immunotherapy improves survival in advanced bladder cancer patients

An immunotherapy drug called 'avelumab' has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial led by Queen Mary University ...

Oncology & Cancer

New target for aggressive bladder cancer

An international team of scientists have discovered a faulty process in certain bladder cancers that could point to new ways to treat patients with an aggressive form of the disease.

Oncology & Cancer

Clinical trial could lead to new bladder cancer drug

A bladder cancer drug tested in a University of Hawai'i Cancer Center clinical trial is getting closer to Food and Drug Administration (FDA) approval. The new drug, an interleukin 15 superagonist complex (ALT-803), combined ...

Oncology & Cancer

Developing a urine test for various types of cancer

Detecting cancer of various types, in a very early stage and using a simple urine sample. That is the ambition of the new startup company NanoMed Diagnostics. Years of research, by scientists of the University of Twente and ...

Oncology & Cancer

Cancer categories recast in largest-ever genomic study

New research partly led by UC San Francisco-affiliated scientists suggests that one in 10 cancer patients would be more accurately diagnosed if their tumors were defined by cellular and molecular criteria rather than by the ...

page 6 from 39